Limb-girdle muscular dystrophy (LGMD) is a group of hereditary muscle diseases with preferential involvement of the shoulder and pelvic girdle muscles, but with no pathognomonic features as in facioscapulohumeral and congenital
muscular dystrophies. We report 18-year-old female with progressive shoulder and pelvic
muscle weakness. She had marked restrictive pulmonary dysfunction. Echocardiogram showed mild decrease in ejection fraction of 52% (normal: >55%). She was first seen in our hospital at age 2 years with progressive proximal
muscle weakness and elevated
creatine kinase (CK) level to 15,290 IU/L, with what clinically and pathologically appeared to be
steroid-responsive
inflammatory myopathy. She responded dramatically to
steroid therapy. Progressive proximal
muscle weakness began again at age 8 years. Serum CK was 14,910 IU/L. She was wheelchair-bound by age 12. Muscle biopsy showed dystrophic changes without
inflammation with reduced immunoreactivity to an antibody against
sugar chain (VIA4-1) of
alpha-dystroglycan. On
laminin overlay assay, there was a nearly complete loss of
laminin-binding activity to
alpha-dystroglycan. Genetic analysis of fukutin-related
protein (FKRP) gene revealed a novel compound heterozygous mutation of c.823C>T (p.R275C) and c.948delC, confirming the diagnosis of
LGMD2I, the first reported case in East Asia.